Flagship explainer
What drives AngioDynamics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$36.7M | FY2026 |
| |
| Income before tax | −$36.3M | FY2026 |
|
| Operating income | −$39.9M | FY2026 |
|
| $320M | FY2026 |
| |
| Ending assets | $267M | FY2026 |
|
| Beginning assets | $280M | FY2025 |
|
| $171M | FY2026 |
| |
| $183M | FY2025 |
|
Source:
- SEC filingFiling detailsAccession 0001628280-26-048138